Pedunculoside exhibits significant anti-inflammatory and immunomodulatory properties, making it a compound of interest in the development of treatments for chronic inflammatory diseases such as arthritis and inflammatory bowel disease. It has been studied for its ability to inhibit key pro-inflammatory cytokines, including TNF-α and IL-6, which play central roles in the progression of inflammation. Additionally, pedunculoside demonstrates hepatoprotective effects, showing potential in protecting the liver from damage caused by toxins or oxidative stress. Its natural origin and low toxicity profile support its exploration as a lead compound in nutraceuticals and phytopharmaceuticals. Research also suggests antiviral activity, particularly against certain enveloped viruses, due to its interference with viral entry into host cells. These diverse biological activities position pedunculoside as a promising candidate for further pharmacological development.